Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OnkoTartis

OnkoTartis
2011 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
$6M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of anti-cancerous drugs designed to help patients recover acute leukemia. The company's anti-cancerous drugs helps to treat leukemia with medical devices and it also develops biochemical and microbiological characteristics of materials and substances in terms of testing and analyzing the product, enabling patients to recover cancer and white cell diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Biotechnology
Primary Office
  • 640 Ellicott Street
  • Suite 480
  • Buffalo, NY 14203
  • United States

+1 (716) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OnkoTartis’s full profile, request a free trial.

OnkoTartis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 11-Dec-2017 $6M 000.00 Completed Generating Revenue
4. Grant 07-Jun-2017 000.00 00.000 Completed Generating Revenue
3. Grant 00.000 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Jul-2016 $1.85M $8.25M Completed Generating Revenue
1. Early Stage VC (Series A) 17-Feb-2011 $6.4M $6.4M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

OnkoTartis Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Quanticel Pharmaceuticals Formerly VC-backed San Francisco, CA 00 0000 000000&0 0000
00000 00000 000000 Venture Capital-Backed Geneva, Switzerland 000 00000 0000000000 0 00000
000000 00000000000 Failed Transaction (M&A) Cambridge, MA 000 00000 000000&0
000000 Venture Capital-Backed Cambridge, United Kingdom 00 0000 000000 - 000 0000
000000000 Formerly VC-backed Exton, PA 000 0000 000000&0 0000
To view this company’s complete list of competitors, request access »

OnkoTartis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Norma Investments Venture Capital Minority 000 0000 000000 0
Pharmstandard Corporation Minority 000 0000 000000 0
Startup Village Other 000 0000 000000 0
Bioprocess Capital Partners Venture Capital Minority 000 0000 000000 0
Skolkovo Foundation Limited Partner 000 0000 000000 0

OnkoTartis Executive Team (5)

Name Title Board
Seat
Contact
Info
Andrei Gudkov Ph.D Co-Founder & Chief Scientific Officer
Aleksandra Kotlyarova Director, Operations
Alexander Polinsky Ph.D Co-Founder & Chief Executive Officer
Olga Chernova Ph.D Co-Founder & Vice President, Research

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »